CMDh: Update of the Q&A List Variations
Recommendation
20 October 2026
Copenhagen, Denmark
An ECA Course prior to the 29th APIC/CEFIC Global GMP & Regulatory API Conference
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
A revision of the "Q&A - List for the submission of variations according to Commission Regulation (EC) 1234/2008" was prepared in May 2020 and published on the HMA (Heads of Medicines Agencies) website. This document lists and answers general questions regarding variation procedures and their submissions for human and veterinary medicinal products.
A new question and its answer have been added in section 1.9 "How do I notify an update of the contact details of the qualified person for pharmacovigilance (QPPV) specified in the application form / Part IA for MRP/DCP or purely nationally authorised products?"
Here, you will find both versions of the Q&A document: with track changes and the final version.
Related GMP News
14.10.2026Bioassays in the United States Pharmacopoeia - Two Chapters come into Force in Spring
14.10.2026EDQM Revises Guidance on Electronic Submissions for CEP Applications
07.10.2026CEP 2.0: EDQM Updates Guidance on the Use of Certificates of Suitability
07.10.2026EDQM Updates Guidance on CEP Sister File Applications
23.09.2026IRIS Portal: EMA expands digital Procedure Management
16.09.2026EMA updates Procedural Guidance for Application Preparation